世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Colorectal Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1451 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、結腸直腸がん診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診断センター、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結腸直腸がん診断・治療の市場動向 ・企業の競争状況、市場シェア ・結腸直腸がん診断・治療の種類別市場規模（診断、治療） ・結腸直腸がん診断・治療の用途別市場規模（病院、診断センター、研究機関） ・結腸直腸がん診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・結腸直腸がん診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸直腸がん診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸直腸がん診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸直腸がん診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Beckman Coulter、Clinical Genomics、Volition RX、EDP Biotech、Epigenomics、Novigenix、Siemens、Quest Diagnostics、Metabiomics） ・結論

Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market
The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Diagnosis and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Diagnosis and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Diagnosis and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Diagnosis and Therapeutics market.

Global Colorectal Cancer Diagnosis and Therapeutics Scope and Market Size
Colorectal Cancer Diagnosis and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnostics
Therapeutics

Segment by Application
Hospitals
Diagnostic centres
Research institutions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Beckman Coulter
Clinical Genomics
Volition RX
EDP Biotech
Epigenomics
Novigenix
Siemens
Quest Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic centres
1.3.4 Research institutions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Perspective (2016-2027)
2.2 Colorectal Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Diagnosis and Therapeutics Industry Dynamic
2.3.1 Colorectal Cancer Diagnosis and Therapeutics Market Trends
2.3.2 Colorectal Cancer Diagnosis and Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnosis and Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnosis and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnosis and Therapeutics Revenue
3.4 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2020
3.5 Colorectal Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
6.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type
9.2.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application
9.3.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country
9.4.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Colorectal Cancer Diagnosis and Therapeutics Introduction
11.1.4 Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Introduction
11.2.4 Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Clinical Genomics
11.3.1 Clinical Genomics Company Details
11.3.2 Clinical Genomics Business Overview
11.3.3 Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.3.4 Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.3.5 Clinical Genomics Recent Development
11.4 Volition RX
11.4.1 Volition RX Company Details
11.4.2 Volition RX Business Overview
11.4.3 Volition RX Colorectal Cancer Diagnosis and Therapeutics Introduction
11.4.4 Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.4.5 Volition RX Recent Development
11.5 EDP Biotech
11.5.1 EDP Biotech Company Details
11.5.2 EDP Biotech Business Overview
11.5.3 EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Introduction
11.5.4 EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.5.5 EDP Biotech Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.6.5 Epigenomics Recent Development
11.7 Novigenix
11.7.1 Novigenix Company Details
11.7.2 Novigenix Business Overview
11.7.3 Novigenix Colorectal Cancer Diagnosis and Therapeutics Introduction
11.7.4 Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.7.5 Novigenix Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Colorectal Cancer Diagnosis and Therapeutics Introduction
11.8.4 Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.8.5 Siemens Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Details
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.9.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.9.5 Quest Diagnostics Recent Development
11.10 Metabiomics
11.10.1 Metabiomics Company Details
11.10.2 Metabiomics Business Overview
11.10.3 Metabiomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.10.4 Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.10.5 Metabiomics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Table 10. Colorectal Cancer Diagnosis and Therapeutics Market Trends
Table 11. Colorectal Cancer Diagnosis and Therapeutics Market Drivers
Table 12. Colorectal Cancer Diagnosis and Therapeutics Market Challenges
Table 13. Colorectal Cancer Diagnosis and Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Diagnosis and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2020)
Table 17. Ranking of Global Top Colorectal Cancer Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colorectal Cancer Diagnosis and Therapeutics Product Solution and Service
Table 21. Date of Enter into Colorectal Cancer Diagnosis and Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Colorectal Cancer Diagnosis and Therapeutics Product
Table 64. Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Product
Table 69. Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Clinical Genomics Company Details
Table 72. Clinical Genomics Business Overview
Table 73. Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Product
Table 74. Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Clinical Genomics Recent Development
Table 76. Volition RX Company Details
Table 77. Volition RX Business Overview
Table 78. Volition RX Colorectal Cancer Diagnosis and Therapeutics Product
Table 79. Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Volition RX Recent Development
Table 81. EDP Biotech Company Details
Table 82. EDP Biotech Business Overview
Table 83. EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Product
Table 84. EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 85. EDP Biotech Recent Development
Table 86. Epigenomics Company Details
Table 87. Epigenomics Business Overview
Table 88. Epigenomics Colorectal Cancer Diagnosis and Therapeutics Product
Table 89. Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Epigenomics Recent Development
Table 91. Novigenix Company Details
Table 92. Novigenix Business Overview
Table 93. Novigenix Colorectal Cancer Diagnosis and Therapeutics Product
Table 94. Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novigenix Recent Development
Table 96. Siemens Company Details
Table 97. Siemens Business Overview
Table 98. Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Siemens Recent Development
Table 100. Quest Diagnostics Company Details
Table 101. Quest Diagnostics Business Overview
Table 102. Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Product
Table 103. Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Quest Diagnostics Recent Development
Table 105. Metabiomics Company Details
Table 106. Metabiomics Business Overview
Table 107. Metabiomics Colorectal Cancer Diagnosis and Therapeutics Product
Table 108. Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Metabiomics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic centres Case Studies
Figure 7. Research institutions Case Studies
Figure 8. Colorectal Cancer Diagnosis and Therapeutics Report Years Considered
Figure 9. Global Colorectal Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Colorectal Cancer Diagnosis and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players in 2020
Figure 14. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2020
Figure 16. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Share by Region (2016-2027)
Figure 38. China Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 58. Beckman Coulter Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 59. Clinical Genomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 60. Volition RX Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 61. EDP Biotech Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 62. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 63. Novigenix Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 64. Siemens Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 65. Quest Diagnostics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 66. Metabiomics Revenue Growth Rate in Colorectal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---